Dividend Details

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE2237.9040.95 (+1.86 %)
PREV CLOSE ( ) 2196.95
OPEN PRICE ( ) 2235.95
BID PRICE (QTY) 2234.20 (20)
OFFER PRICE (QTY) 2237.95 (11)
VOLUME 27852
TODAY'S LOW / HIGH ( )2206.00 2302.00
52 WK LOW / HIGH ( )1179.95 2201
NSE2235.0038.65 (+1.76 %)
PREV CLOSE( ) 2196.35
OPEN PRICE ( ) 2216.00
BID PRICE (QTY) 2234.00 (28)
OFFER PRICE (QTY) 2235.00 (94)
VOLUME 511430
TODAY'S LOW / HIGH( ) 2205.00 2303.00
52 WK LOW / HIGH ( )1178 2200

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.